Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05505357
What this trial is testing

Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 533
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752394
What this trial is testing

Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma

Who this might be right for
Head & Neck Cancer
Tang-Du Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT05475678
What this trial is testing

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast CancerCamrelizumab
Zhenzhen Liu 369
Not applicableLooking for participantsNCT04815694
What this trial is testing

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy

Who this might be right for
Neoadjuvant ChemoradiotherapyLocally Advanced Rectal CancerPathological Complete Response
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 179
Large-scale testing (Phase 3)UnknownNCT03349177
What this trial is testing

Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerPathological Complete ResponseNeoadjuvant Chemotherapy
Zhiyong Yu 200
Not applicableUnknownNCT05441098
What this trial is testing

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 1,821
Testing effectiveness (Phase 2)Looking for participantsNCT07586826
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGynecologic Cancers+7 more
Peking University People's Hospital 220
Large-scale testing (Phase 3)Looking for participantsNCT06312137
What this trial is testing

Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Who this might be right for
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC 780
Testing effectiveness (Phase 2)Study completedNCT00093639
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate

Who this might be right for
Leukemia
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01216644
What this trial is testing

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Krankenhaus Nordwest 716
Not applicableNo Longer AvailableNCT04501757
What this trial is testing

Naxitamab and GM-CSF in People With Neuroblastoma

Who this might be right for
High-Risk Neuroblastoma
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT06061263
What this trial is testing

Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy

Who this might be right for
Esophageal Cancer
Sun Yat-sen University 96
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Testing effectiveness (Phase 2)Ended earlyNCT03148756
What this trial is testing

Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis

Who this might be right for
EndocarditisBacteremia
AbbVie 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT07421141
What this trial is testing

De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerEarly Breast Cancer
National Medical Research Radiological Centre of the Ministry of Health of Russia 186
Testing effectiveness (Phase 2)Looking for participantsNCT07507318
What this trial is testing

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

Who this might be right for
Diffuse Large B-Cell Lymphoma
Rong Tao 69
Not applicableUnknownNCT02600442
What this trial is testing

Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

Who this might be right for
Breast NeoplasmsBreast Cancer
Assistance Publique - Hôpitaux de Paris 168
Testing effectiveness (Phase 2)Study completedNCT00045422
What this trial is testing

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07646301
What this trial is testing

Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsLocally Advanced
Sun Yat-sen University 103
Testing effectiveness (Phase 2)WithdrawnNCT06180863
What this trial is testing

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
Yale University
Next Page